Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Rajesh Malik. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Rajesh Malik har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:GTHX / G1 Therapeutics, Inc. Chief Medical Officer 0
US:PNT / POINT Biopharma Global Inc. Director 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Rajesh Malik. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Rajesh Malik som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2024-09-18 2024-09-18 4 GTHX G1 Therapeutics, Inc.
Common Stock
U - Other -87.450 0 -100,00
2024-09-18 2024-09-18 4 GTHX G1 Therapeutics, Inc.
Common Stock
D - Sale to Issuer -89.762 87.450 -50,65
2024-09-18 2024-09-18 4 GTHX G1 Therapeutics, Inc.
Common Stock
A - Award 17.900 177.212 11,24
2024-07-08 2024-07-05 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale -2.475 159.312 -1,53 2,51 -6.207 399.507
2024-05-15 2024-05-13 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale -8.151 161.787 -4,80 4,79 -39.034 774.766
2024-02-13 2024-02-12 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -28.600 169.938 -14,41 4,62 -132.143 785.182
2024-02-13 2024-02-12 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 28.600 198.538 16,83 0,30 8.580 59.561
2024-01-08 2024-01-04 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale -721 169.938 -0,42 2,94 -2.121 500.009
2024-01-08 2024-01-03 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale -2.261 170.659 -1,31 3,12 -7.052 532.268
2024-01-08 2024-01-03 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale -758 172.920 -0,44 3,12 -2.364 539.320
2024-01-08 2024-01-03 4 GTHX G1 Therapeutics, Inc.
Common Stock
A - Award 37.300 173.678 27,35
2023-12-27 2023-12-26 4 PNT POINT Biopharma Global Inc.
Common Stock
U - Other -3.700 0 -100,00
2023-12-13 2023-12-11 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -12.400 136.378 -8,33 4,02 -49.863 548.403
2023-12-13 2023-12-11 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 12.400 148.778 9,09 0,30 3.720 44.633
2023-12-13 2023-12-11 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -21.439 136.378 -13,58 3,06 -65.659 417.671
2023-12-13 2023-12-11 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 21.439 157.817 15,72 0,39 8.361 61.549
2023-07-07 2023-07-05 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -1.361 136.378 -0,99 2,45 -3.339 334.631
2023-05-12 2023-05-10 4 GTHX G1 Therapeutics, Inc.
Common Stock
A - Award 35.000 137.739 34,07
2023-01-05 2023-01-05 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale -729 102.739 -0,70 5,41 -3.942 555.561
2023-01-05 2023-01-04 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale -1.639 103.468 -1,56 5,58 -9.138 576.896
2023-01-05 2023-01-03 4 GTHX G1 Therapeutics, Inc.
Common Stock
A - Award 17.900 105.107 20,53
2022-12-16 2022-12-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 14.000 87.207 19,12 0,30 4.200 26.162
2022-11-28 2022-11-28 4 PNT POINT Biopharma Global Inc.
Common Stock
P - Purchase 3.700 3.700 6,66 24.642 24.642
2022-09-16 2022-09-13 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -18.000 73.207 -19,74 15,71 -282.746 1.149.943
2022-09-16 2022-09-13 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 18.000 91.207 24,59 0,39 7.020 35.571
2022-07-06 2022-07-05 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale -648 73.207 -0,88 5,17 -3.351 378.590
2022-02-02 2022-02-01 4 GTHX G1 Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -10.000 55.000 -15,38
2022-02-02 2022-02-01 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 10.000 73.855 15,66 0,30 3.000 22.156
2022-01-05 2022-01-05 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale -1.445 63.855 -2,21 10,61 -15.334 677.597
2022-01-05 2022-01-03 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to buy)
A - Award 53.000 53.000
2022-01-05 2022-01-03 4 GTHX G1 Therapeutics, Inc.
Common Stock
A - Award 12.000 65.300 22,51
2021-07-08 2021-07-06 4 PNT POINT Biopharma Global Inc.
Stock Option (Right to Buy)
A - Award 25.000 25.000
2021-05-11 2021-05-10 4 GTHX G1 Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -10.000 65.000 -13,33
2021-05-11 2021-05-10 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 10.000 53.300 23,09 0,30 3.000 15.990
2021-04-23 2021-04-22 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -15.000 39.439 -27,55
2021-04-23 2021-04-22 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -15.000 43.300 -25,73 22,07 -331.100 955.774
2021-04-23 2021-04-22 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 15.000 58.300 34,64 0,39 5.850 22.737
2021-03-24 2021-03-23 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -15.000 54.439 -21,60
2021-03-24 2021-03-23 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -15.000 43.300 -25,73 21,94 -329.060 949.885
2021-03-24 2021-03-23 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 15.000 58.300 34,64 0,39 5.850 22.737
2021-03-04 2021-03-02 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -10.405 69.439 -13,03
2021-03-04 2021-03-02 4 GTHX G1 Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -4.595 36.924 -11,07
2021-03-04 2021-03-02 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -15.000 43.300 -25,73 22,95 -344.192 993.566
2021-03-04 2021-03-02 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 4.595 58.300 8,56 4,17 19.161 243.111
2021-03-04 2021-03-02 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 10.405 53.705 24,03 0,39 4.058 20.945
2021-01-29 2021-01-27 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -3.100 79.844 -3,74
2021-01-29 2021-01-27 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 3.100 43.300 7,71 0,39 1.209 16.887
2021-01-22 2021-01-22 4 GTHX G1 Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -15.000 41.519 -26,54
2021-01-22 2021-01-22 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -15.000 40.200 -27,17 20,64 -309.591 829.704
2021-01-22 2021-01-22 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 15.000 55.200 37,31 4,17 62.550 230.184
2021-01-05 2021-01-04 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
A - Award 58.000 58.000
2021-01-05 2021-01-04 4 GTHX G1 Therapeutics, Inc.
Common Stock
A - Award 11.000 40.200 37,67
2020-12-11 2020-12-10 4 GTHX G1 Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -9.000 56.519 -13,74
2020-12-11 2020-12-10 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -9.000 29.200 -23,56 20,06 -180.550 585.784
2020-12-11 2020-12-10 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 9.000 38.200 30,82 4,17 37.530 159.294
2020-03-16 2020-03-13 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -2.500 82.944 -2,93
2020-03-16 2020-03-13 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 2.500 29.200 9,36 0,39 975 11.388
2020-02-07 2020-02-06 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
A - Award 60.000 60.000
2020-01-24 2020-01-23 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -5.000 85.444 -5,53
2020-01-24 2020-01-23 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 5.000 26.700 23,04 0,39 1.950 10.413
2019-01-28 2019-01-28 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -7.000 90.444 -7,18
2019-01-28 2019-01-28 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 7.000 21.700 47,62 0,39 2.730 8.463
2019-01-02 2019-01-02 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
A - Award 60.000 60.000
2018-12-17 2018-12-17 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -3.776 65.519 -5,45
2018-12-17 2018-12-17 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -3.776 14.700 -20,44 30,00 -113.280 441.000
2018-12-17 2018-12-17 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 3.776 18.476 25,69 4,17 15.746 77.045
2018-11-16 2018-11-15 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -3.776 69.295 -5,17
2018-11-16 2018-11-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -247 14.700 -1,65 40,31 -9.958 592.616
2018-11-16 2018-11-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -3.529 14.947 -19,10 39,71 -140.147 593.590
2018-11-16 2018-11-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 3.776 18.476 25,69 4,17 15.746 77.045
2018-10-15 2018-10-15 4 GTHX G1 Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -6.300 97.444 -6,07
2018-10-15 2018-10-15 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -3.776 73.071 -4,91
2018-10-15 2018-10-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 6.300 14.700 75,00 0,39 2.457 5.733
2018-10-15 2018-10-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -2.833 8.400 -25,22 42,01 -119.019 352.897
2018-10-15 2018-10-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -943 11.233 -7,74 40,80 -38.478 458.352
2018-10-15 2018-10-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 3.776 12.176 44,95 4,17 15.746 50.774
2018-09-19 2018-09-17 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -3.776 76.847 -4,68
2018-09-19 2018-09-17 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -300 8.400 -3,45 67,95 -20.385 570.780
2018-09-19 2018-09-17 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -484 8.700 -5,27 66,77 -32.317 580.905
2018-09-19 2018-09-17 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -2.992 9.184 -24,57 65,78 -196.800 604.080
2018-09-19 2018-09-17 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 3.776 12.176 44,95 4,17 15.746 50.774
2018-08-17 2018-08-15 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -3.776 80.623 -4,47
2018-08-17 2018-08-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -1.700 8.400 -16,83 56,50 -96.049 474.595
2018-08-17 2018-08-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -2.076 10.100 -17,05 55,38 -114.974 559.361
2018-08-17 2018-08-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 3.776 12.176 44,95 4,17 15.746 50.774
2018-07-17 2018-07-16 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -3.776 84.399 -4,28
2018-07-17 2018-07-16 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -1.262 8.400 -13,06 42,70 -53.888 358.687
2018-07-17 2018-07-16 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -2.514 9.662 -20,65 41,91 -105.359 404.925
2018-07-17 2018-07-16 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 3.776 12.176 44,95 4,17 15.746 50.774
2018-06-18 2018-06-15 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -3.776 88.175 -4,11
2018-06-18 2018-06-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -3.776 8.400 -31,01 44,31 -167.326 372.230
2018-06-18 2018-06-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 3.776 12.176 44,95 4,17 15.746 50.774
2018-06-11 2018-06-08 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -4.200 103.744 -3,89
2018-06-11 2018-06-08 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 4.200 8.400 100,00 0,39 1.638 3.276
2018-05-16 2018-05-15 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -3.776 91.951 -3,94
2018-05-16 2018-05-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -100 4.200 -2,33 46,67 -4.667 196.014
2018-05-16 2018-05-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -3.676 4.300 -46,09 46,29 -170.154 199.038
2018-05-16 2018-05-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 3.776 7.976 89,90 4,17 15.746 33.260
2018-04-17 2018-04-16 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -3.776 95.727 -3,79
2018-04-17 2018-04-16 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -500 4.200 -10,64 36,71 -18.355 154.182
2018-04-17 2018-04-16 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -3.276 4.700 -41,07 35,95 -117.780 168.976
2018-04-17 2018-04-16 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 3.776 7.976 89,90 4,17 15.746 33.260
2018-03-16 2018-03-15 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -3.280 0 -100,00
2018-03-16 2018-03-15 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -496 99.503 -0,50
2018-03-16 2018-03-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -3.776 4.200 -47,34 38,18 -144.151 160.338
2018-03-16 2018-03-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 3.280 7.976 69,85 0,39 1.279 3.111
2018-03-16 2018-03-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 496 4.696 11,81 4,17 2.068 19.582
2018-03-09 2018-03-08 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -4.200 107.944 -3,75
2018-03-09 2018-03-08 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 4.200 4.200 0,39 1.638 1.638
2018-02-16 2018-02-15 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -2.890 0 -100,00
2018-02-16 2018-02-15 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -886 3.280 -21,27
2018-02-16 2018-02-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -3.776 0 -100,00 20,00 -75.520
2018-02-16 2018-02-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 886 3.776 30,66 0,39 346 1.473
2018-02-16 2018-02-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 2.890 2.890 0,30 867 867
2018-01-17 2018-01-16 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -3.776 2.890 -56,65
2018-01-17 2018-01-16 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -3.776 0 -100,00 22,96 -86.693
2018-01-17 2018-01-16 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 3.776 3.776 0,30 1.133 1.133
2018-01-04 2018-01-02 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
A - Award 50.000 50.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)